109 related articles for article (PubMed ID: 4678189)
1. [The pathogenesis of hyperthyreosis].
Scazziga BR
Ther Umsch; 1972 Sep; 29(9):550-3. PubMed ID: 4678189
[No Abstract] [Full Text] [Related]
2. Current concepts concerning the pathogenesis of the hyperthyroidism of Graves' disease.
Orth DN
J Tenn Med Assoc; 1967 Jan; 60(1):41-7. PubMed ID: 5343003
[No Abstract] [Full Text] [Related]
3. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
4. The long-acting thyroid stimulator and thyroid disease.
Kriss JP
Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
[No Abstract] [Full Text] [Related]
5. [Etiopathogenesis of thyrotoxicosis].
de Medeiros Neto GA
Rev Paul Med; 1967 Jan; 70(1):48-52. PubMed ID: 5631892
[No Abstract] [Full Text] [Related]
6. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
Földes J; Takó J; Bános C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
[No Abstract] [Full Text] [Related]
7. [Etiology of Basedow's disease, with special reference to LATS].
Nagata K
Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
[No Abstract] [Full Text] [Related]
8. [Long acting thyroid stimulating immunoglobulin in pathogenesis of diffused thyrotoxicosis (author's transl)].
Zao WS; Wang SZ
Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):119-25. PubMed ID: 6895561
[No Abstract] [Full Text] [Related]
9. Aetiology of hyperthyroidism. II.
Hoffenberg R
Br Med J; 1974 Aug; 3(5929):508-10. PubMed ID: 4369764
[No Abstract] [Full Text] [Related]
10. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
Studer H
Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
[No Abstract] [Full Text] [Related]
11. The pathogenesis of hyperthyroidism.
McKenzie JM
Triangle; 1969; 9(1):2-8. PubMed ID: 5820145
[No Abstract] [Full Text] [Related]
12. The long-acting thyroid stimulator.
Munro DS
J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
[No Abstract] [Full Text] [Related]
13. Humoral factors in the pathogenesis of Graves' disease.
McKenzie JM
Physiol Rev; 1968 Jan; 48(1):252-310. PubMed ID: 4865519
[No Abstract] [Full Text] [Related]
14. [The thyroid activator with prolonged action, L.A.T.S., and the mechanism of hyperthyroidism].
Savoie JC
Rev Fr Etud Clin Biol; 1967 Dec; 12(10):941-5. PubMed ID: 5632211
[No Abstract] [Full Text] [Related]
15. [The long-acting thyroid stimulator (LATS)].
Masala C
Folia Allergol (Roma); 1969; 16(3):249-63. PubMed ID: 4931876
[No Abstract] [Full Text] [Related]
16. [Modern views on the physiopathology and pathogenesis of hyperthyroidism].
Gasiorowski W
Pol Arch Med Wewn; 1971; 46(4):401-7. PubMed ID: 5108484
[No Abstract] [Full Text] [Related]
17. [Significance of thyroid gland stimulating factors (LATS and LATS-protector) for the disease course of hyperthyroidism].
Wuttke H
Verh Dtsch Ges Inn Med; 1975; 81():1552-4. PubMed ID: 1227022
[No Abstract] [Full Text] [Related]
18. [Long-acting thyroid stimulator (L.A.T.S.) and its place in the physiopathogeny of Basedowian hyperthyroidism].
Guéritée N
Rev Fr Endocrinol Clin; 1968; 9(4):351-66. PubMed ID: 5755332
[No Abstract] [Full Text] [Related]
19. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
20. Long-acting thyroid stimulator: A review.
Joasoo A
Med J Aust; 1970 Mar; 1(12):595-8. PubMed ID: 4910668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
